Compounding pharmacies have been the subject of at least 14 multistate recalls this year, usually due to sterility concerns, the Wall Street Journal reports. In 2012, the FDA reported only two compounder recalls, including one associated with the fungal meningitis outbreak that sickened over 700 and killed 63.

- See more at: http://www.jwatch.org/fw107879/2013/09/11/compounding-pharmacy-recalls-rise-fda-oversight-proposed#sthash.GjN4pGbl.dpuf